KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Cardlytics (CDLX) over the last 8 years, with Q3 2025 value amounting to 0.51%.

  • Cardlytics' Return on Capital Employed rose 4200.0% to 0.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51%, marking a year-over-year increase of 4200.0%. This contributed to the annual value of 0.58% for FY2024, which is 2900.0% down from last year.
  • Cardlytics' Return on Capital Employed amounted to 0.51% in Q3 2025, which was up 4200.0% from 0.78% recorded in Q2 2025.
  • Cardlytics' Return on Capital Employed's 5-year high stood at 0.06% during Q1 2022, with a 5-year trough of 0.97% in Q1 2023.
  • For the 5-year period, Cardlytics' Return on Capital Employed averaged around 0.47%, with its median value being 0.36% (2024).
  • In the last 5 years, Cardlytics' Return on Capital Employed plummeted by -9000bps in 2023 and then surged by 6000bps in 2024.
  • Over the past 5 years, Cardlytics' Return on Capital Employed (Quarter) stood at 0.13% in 2021, then plummeted by -444bps to 0.73% in 2022, then surged by 57bps to 0.31% in 2023, then crashed by -153bps to 0.79% in 2024, then soared by 35bps to 0.51% in 2025.
  • Its last three reported values are 0.51% in Q3 2025, 0.78% for Q2 2025, and 0.75% during Q1 2025.